General Inception
Startup
The mission of Ennovate is to harness the power of innate immunity to conquer autoimmune and inflammatory disease space by delivering breakthrough medicine to non-responder patients of current cytokine-based standard care treatments.
Ennovate will advance therapeutic antibodies in an expedient manner, leveraging cutting-edge multiplexing analyses across multiple indications, to identify therapeutically tractable cell types and targets. Current Ennovate pipeline is composed of two lead projects focused on targeting mast cells and eosinophils (ENNOV-001) and blocking a key cytokine node (ENNOV-002), representing the next generation of biologics for non-responders.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events